You Jin Ku1,2, Hak Hee Kim1, Joo Hee Cha1, Hee Jung Shin1, Soo Heui Baek1, Hee Jin Lee3, Gyungyub Gong3. 1. 1 Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-Gu, Seoul 05505, Korea. 2. 2 Present address: Department of Radiology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea. 3. 3 Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Abstract
OBJECTIVE: Increased levels of tumor-infiltrating lymphocytes (TILs) positively correlate with the pathologic complete response rate and increased survival in patients with triple-negative breast cancer (TNBC). The purpose of this study was to investigate associations between TIL levels and MRI findings in patients with TNBC. MATERIALS AND METHODS: From February 2006 through December 2014, a total of 112 women with TNBC were selected for inclusion in the study. All lesions were evaluated by radiologists in accordance with the BI-RADS lexicon. Lymph node involvement and multifocality were also assessed. Tumors were divided into two groups: those with a TIL level of less than 50% were included in the group with low TIL levels (hereafter referred to as the "low-TIL group"), and those with a TIL level of 50% or more were included in the group with high TIL levels (hereafter referred to as the "high-TIL group"). Associations between TIL levels and imaging features were evaluated. RESULTS: Tumors in the high-TIL group had a more round shape (46.0%), a circumscribed margin (76.0%), homogeneous enhancement (32.0%), and absence of multifocality (88.0%) (p < 0.005). Tumors in the low-TIL group had a more irregular shape (69.3%), no circumscribed margin (79.0%), heterogeneous enhancement (75.8%), and multifocality (70.9%) (p < 0.005). CONCLUSION: The well-known typical features of TNBC on MRI, including a round shape, a circumscribed margin, homogeneous enhancement, and lack of multifocality, are a major pattern of TNBC with high TIL levels. This information could provide added diagnostic benefit for the identification of tumors with a good prognosis, which could further assist in optimal pretreatment planning.
OBJECTIVE: Increased levels of tumor-infiltrating lymphocytes (TILs) positively correlate with the pathologic complete response rate and increased survival in patients with triple-negative breast cancer (TNBC). The purpose of this study was to investigate associations between TIL levels and MRI findings in patients with TNBC. MATERIALS AND METHODS: From February 2006 through December 2014, a total of 112 women with TNBC were selected for inclusion in the study. All lesions were evaluated by radiologists in accordance with the BI-RADS lexicon. Lymph node involvement and multifocality were also assessed. Tumors were divided into two groups: those with a TIL level of less than 50% were included in the group with low TIL levels (hereafter referred to as the "low-TIL group"), and those with a TIL level of 50% or more were included in the group with high TIL levels (hereafter referred to as the "high-TIL group"). Associations between TIL levels and imaging features were evaluated. RESULTS:Tumors in the high-TIL group had a more round shape (46.0%), a circumscribed margin (76.0%), homogeneous enhancement (32.0%), and absence of multifocality (88.0%) (p < 0.005). Tumors in the low-TIL group had a more irregular shape (69.3%), no circumscribed margin (79.0%), heterogeneous enhancement (75.8%), and multifocality (70.9%) (p < 0.005). CONCLUSION: The well-known typical features of TNBC on MRI, including a round shape, a circumscribed margin, homogeneous enhancement, and lack of multifocality, are a major pattern of TNBC with high TIL levels. This information could provide added diagnostic benefit for the identification of tumors with a good prognosis, which could further assist in optimal pretreatment planning.
Entities:
Keywords:
MRI; optimal planning; prognosis; triple-negative breast cancer; tumor-infiltrating lymphocytes
Authors: Mirella L Altoe; Kevin Kalinsky; Alessandro Marone; Hyun K Kim; Hua Guo; Hanina Hibshoosh; Mariella Tejada; Katherine D Crew; Melissa K Accordino; Meghna S Trivedi; Dawn L Hershman; Andreas H Hielscher Journal: Clin Cancer Res Date: 2021-01-15 Impact factor: 12.531
Authors: Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi Journal: Breast Cancer Res Date: 2017-05-18 Impact factor: 6.466
Authors: Nathaniel Braman; Prateek Prasanna; Jon Whitney; Salendra Singh; Niha Beig; Maryam Etesami; David D B Bates; Katherine Gallagher; B Nicolas Bloch; Manasa Vulchi; Paulette Turk; Kaustav Bera; Jame Abraham; William M Sikov; George Somlo; Lyndsay N Harris; Hannah Gilmore; Donna Plecha; Vinay Varadan; Anant Madabhushi Journal: JAMA Netw Open Date: 2019-04-05